Post Mortem Study On 10 COVID-19 Patients Shows Major Damage To Lungs, Kidneys
Covid-19 is being investigated for its lasting effect on the human body. New post-mortem examinations performed on COVID-19 patients now show that the disease results in injuries to lungs as well as kidneys of its host body.
The post mortem was conducted by Dr Brian Hanley from the Department of Cellular Pathology at Imperial College Healthcare NHS Trust and his team. “In the patients we looked at, we also saw evidence of kidney injuries and in some cases, pancreatitis,” mentions Dr Hanley.
The one of its kind study affirms several researches on the topic. While the theories existed, the new study supports them with findings that “lung injuries, thrombosis, and immune cell depletion are the most prominent features in severe cases of Covid-19”.
For the study, the researchers conducted post-mortem examinations on a total of ten COVID-19 patients. In these patients, scientists found that high blood pressure and chronic obstructive pulmonary disease - a group of lung conditions that cause breathing difficulties - were the most common contributing factors to death.
The study finds that all the patients developed a fever and at least two respiratory symptoms, like cough and shortness of breath, during the early stages of the disease. Most of these patients died within three weeks of the first appearance of the symptoms.
Scientists also found that nine of the ten patients died due to some form of thrombosis- a blood clot - in at least one major organ. Blood clots like these are the leading cause of strokes and heart attacks as they prevent the normal flow of the blood in the human body.
Thrombi was found in the lungs of eight patients, the heart of five patients, and the kidneys of four patients. The researchers believe that this is a proof that Covid-19 causes circulatory complications. They thus argue that the treatment of the patients can thus be augmented with blood-thinning medication to prevent blood clots.
This is the whole purpose of the study, to help guide clinicians better treat complications resulting from COVID-19. The researchers hope that a better understanding of the key complications in severe cases could help clinicians develop new ways to fight the disease.
(With inputs from ANI)